Skip to content

Sore Throat After Open Neck Elective Surgery

Effect of Hydrocortisone and Lidocaine on Endotracheal Tube for Sore Throat and Hoarseness After Thyroid/Parathyroid Surgery With Neuromonitoring: A Randomized Controlled Trial

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07124650
Acronym
STONES
Enrollment
764
Registered
2025-08-15
Start date
2025-09-15
Completion date
2027-05-31
Last updated
2025-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Sore Throat, Cough, Hoarseness, Thyroid and Parathyroid Surgery

Keywords

Hydrocortisone, Lidocaine, Endotracheal tube, Neuromonitoring, Randomized controlled trial

Brief summary

This randomized, double-blind clinical trial aims to evaluate the effectiveness of two medications-hydrocortisone ointment and lidocaine solution-applied to the endotracheal tube in reducing postoperative throat pain, hoarseness, and cough following thyroid or parathyroid surgery with neuromonitoring. A total of 764 adult patients undergoing elective neck surgery at Saint-Petersburg State University Hospital will be enrolled and randomly assigned to receive either a hydrocortisone-coated or lidocaine-coated endotracheal tube. Outcomes will be assessed upon awakening from anesthesia, at 24 hours, and again at 3 days postoperatively. The findings may contribute to improving postoperative comfort and recovery for patients undergoing similar surgical procedures.

Interventions

Endotracheal tubes will be coated with 1% hydrocortisone acetate ointment prior to intubation. The ointment will be applied uniformly to the outer surface of the tube. This intervention aims to reduce postoperative throat inflammation and pain.

DRUGLidocaine hydrochloride 0,05% with chlorhexidine

Endotracheal tubes will be treated with 0.05% lidocaine hydrochloride solution combined with chlorhexidine (Cathejell). The solution will be applied to the tube surface before intubation to provide local anesthesia and reduce postoperative throat discomfort.

Sponsors

Smooth Drug Development
CollaboratorUNKNOWN
Saint Petersburg State University, Russia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients scheduled for elective open surgery on the thyroid/parathyroid glands with intraoperative neuromonitoring. * Age ≥18 years. * Willing and able to provide voluntary informed consent for participation in the study.

Exclusion criteria

* Pregnancy (for women of childbearing potential). * Known allergy to hydrocortisone or lidocaine. * Refusal to participate in the study.

Design outcomes

Primary

MeasureTime frameDescription
Frequency of severe throat pain at 24 hours post-operation24 hours post-operationProportion of patients scoring ≥3 points on the STONES throat pain subscale (0 = no pain, 1 = mild, 2 = moderate, 3 = severe pain) assessed 24 hours after thyroid/parathyroid surgery. Evaluated through patient-reported questionnaire administered by a blinded investigator.
Frequency of clinically significant EMG signal reductionPerioperative/periproceduralProportion of patients showing ≥50% decrease in amplitude of electromyographic (EMG) signals from recurrent laryngeal nerve during intraoperative neuromonitoring compared to baseline measurements (V1/ R1 timepoints), using the C2 neuromonitor system.

Secondary

MeasureTime frameDescription
Frequency of intraoperative laryngeal reflexes (coughing)Perioperative/periproceduralNumber of coughing episodes recorded by anesthesiologist during surgical procedure, graded as: 0 = no cough, 1 = single mild cough, 2 = persistent cough requiring intervention.
Episodes of complete EMG signal loss during surgeryPerioperative/periproceduralNumber of events with total loss of electromyographic response (OmV amplitude) during stimulation of recurrent laryngeal nerve, confirmed by repeated measurements at standard timepoints (V1/R1 to V2/R2).
Vocal cord mobility impairment (laryngoscopy)72 hours after surgeryPresence of unilateral/bilateral vocal cord paralysis or paresis detected through postoperative fiberoptic laryngoscopic examination, graded as: 0 = normal mobility, 1 = reduced mobility, 2 = complete paralysis.
Neck Disability Index (NDI) score3 days after surgeryPatient-reported functional limitation score (0-50 scale) assessing neck pain impact on daily activities, with higher scores indicating greater disability. Collected through standardized questionnaire.

Countries

Russia

Contacts

Primary ContactSergey M. Efremov, D. Med. Sc.
efremovsergm@gmail.com+79137946090
Backup ContactAlexey Y. Kulikov, Ph. D. (Med.)
alexeykulikov1987@yandex.ru+79217896909

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026